Stocks In News: Skyworks Solutions Inc (NASDAQ:SWKS), Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), Globalstar, Inc. (NYSEMKT:GSAT)

Flavia Carruth - October 16, 2014

Boston, MA 10/16/2014 (wallstreetpr) – Skyworks Solutions Inc (NASDAQ:SWKS) which is into the manufacture of Analog semiconductors provided a better than expected earnings and revenue guidance for its fourth quarter operations. On the back of the positive outlook the stock posted a steady 1.4 percent increase in its share price yesterday.

The company has decided to increase its forecast for the year ending quarter in order to better capture the positive marketed conditions and the firm’s ability to make the best of the situation through its existing capacity.

As per the new forecast, the firm expects to see its 4Q revenue jump up by 51 percent as compared to same quarter last year to peak at $718 million. EPS per share is expected to come in at $1.08, which would translate to a 69 percent over same quarter, last year compare.

At the beginning of the fourth quarter, Skyworks Solutions Inc (NASDAQ:SWKS) had anticipated a 43 percent increase in revenue and anticipated bringing in $680 million.

Biopharmaceutical firm Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) announced recently that it had granted 15 of its new employees stock options to buy an total of 36,750 shares of common stock as part of its campaign new blood into the company. The stocks are being allotted under the inducement stock option program.

Each of the options is worth $33.56 per share. 25 percent of the stock would be vested with the company after her completes one year with the company. The reminder 75 percent gets vested in equally monthly instalments which are spread out over a 36 month period.

Globalstar, Inc. (NYSEMKT:GSAT) has responded to the unfavourable commentary provided by analysts at Kerrisdale Capital by stating that the trading house is attempting to short sell the price of Globalstar, Inc. (NYSEMKT:GSAT) stock for its own financial benefits. It goes on to state that its business modal remains robust and beyond reproach.


Flavia Carruth

Hi, I am Flavia and have done my MBA with finance as specialization and a Bachelor in Economics with 4 years of experience as Financial Analyst in leading Software Firm. I have passion for article writing, report making and stock market Analysis.

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign Up To Get Our Latest Stocks Alerts